At one point, HCW had a price target of $4 for us. Then later they had one at only $1. TBH, I would be happy with either price target these days. Having a review and rating from any IB would be nice. Our greatest weakness has always been financing, including only having retail investors. It would be great to get some institutional investors behind us.